Landscapes / Companies
Durect not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 5 in all
Trials
0 active
12 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Bausch Health Americas |
Phase 3 | Nov 2027Phase 3 trial completes | ||
| Next date | Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Hepatitis | ||||
| Open drug page | |||||
About
- No active trial
- Bupivacaine TTS, SABER-Bupivacaine, SABER-Bupivacaine Treatment 1a, SABER-Bupivacaine Treatment 2a
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021